izvor podataka: crosbi
✓
Genetic polymorphism of CYP2C9 and warfarin dose predicting in anticoagulation therapy (CROSBI ID 739941)
Prilog sa skupa u časopisu | izvorni znanstveni rad
Štefanović, Mario ; Topić, Elizabeta ; Samardžija, Marina
Genetic polymorphism of CYP2C9 and warfarin dose predicting in anticoagulation therapy // Clinical chemistry (Baltimore, Md.). 2005. str. A151-x
Podaci o odgovornosti
Štefanović, Mario ; Topić, Elizabeta ; Samardžija, Marina
engleski
Genetic polymorphism of CYP2C9 and warfarin dose predicting in anticoagulation therapy
Warfarin (racemic mixture of S- and R- enantiomers) is an anticoagulant therapy drug which is often associated with unwanted side effects such as serious bleeding.
CYP2C9 genotyping; warfarin; anticoagulant therapy
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
A151-x.
2005.
nije evidentirano
objavljeno
Podaci o matičnoj publikaciji
Clinical chemistry (Baltimore, Md.)
0009-9147
Podaci o skupu
Nepoznat skup
ostalo
29.02.1904-29.02.2096
Povezanost rada
Povezane osobe
Povezane ustanove
